Pharming (PHAR) Current Taxes (2020 - 2026)

Pharming's (PHAR) quarterly Current Taxes came in at $72.4 million in Q1 2024, down 4.86% on a QoQ basis from $76.1 million in Q4 2023.

Analysis

Pharming (PHAR) Current Taxes (2020 - 2026) Analysis & Trends

Pharming (PHAR) has 2 years of Current Taxes data on file, last reported at $72.4 million in Q1 2024.

Quarterly Current Taxes changed N/A year-over-year to $72.4 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $72.4 million (changed N/A YoY) and the FY2023 annual result came in at $76.1 million, changed N/A from the prior year.
Current Taxes retreated to $72.4 million in Q1 2024, from $76.1 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $76.1 million in Q4 2023 to a low of $72.4 million in Q1 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	76.32 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Pharming	794.84 Mn	635.34 Mn	141.47 Mn	5.47 Mn

Historic Data

Download Data